Quantcast
Cholesterol Drug Cuts Heart And Stroke Risks In Diabetic

Cholesterol Drug Cuts Heart And Stroke Risks In Diabetic Women: Study

Dan Gafney, University of Sydney The cholesterol-lowering drug fenofibrate cuts cardiovascular disease risks by 30 percent in women with type-2 diabetes, a new University of Sydney study reveals. "The finding is good news for women," says...

Latest Lipoproteins Stories

2014-08-28 08:28:39

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Aug. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol Reduction Using a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular Risk) study evaluating evolocumab in combination with statin therapy in Japanese patients with high cardiovascular risk and high cholesterol met its co-primary endpoints: the percent...

2014-08-28 08:27:42

CARLSBAD, Calif., Aug. 28, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 3 study evaluating ISIS-APOCIII(Rx) in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide. The Phase 3 study of ISIS-APOCIII(Rx) is a randomized, double-blind, placebo-controlled, six month study in approximately...

2014-08-20 23:03:06

The research organization offers tips on how to help lower cholesterol. San Antonio, TX (PRWEB) August 20, 2014 Texas Medical Research Associates is looking for candidates to participate in their new study. The study will help test the effectiveness of a new drug looking to help lower cholesterol. People who suffer from high cholesterol may be eligible to participate in the study. According to the American Heart Association, too much cholesterol in the blood can lead to cardiovascular...

statins
2014-08-17 02:00:52

Traci Klein, Mayo Clinic A Mayo Clinic task force challenges some recommendations in the updated guideline for cholesterol treatment unveiled by the American College of Cardiology (ACC) and American Heart Association (AHA) in 2013. The task force concludes, based on current evidence, that not all patients encouraged to take cholesterol-lowering medications, such as statins, may benefit from them and that the guideline missed some important conditions that might benefit from medication....

2014-08-12 12:29:20

LONDON, Aug. 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Hypercholesterolemia Market 2014-2018https://www.reportbuyer.com/product/2183843/Global-Hypercholesterolemia-Market-2014-2018.html About HypercholesterolemiaHypercholesterolemia is defined as a condition characterized by abnormally high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to cardiovascular diseases such as...

2014-07-23 08:32:18

In addition, preliminary results from an Australian sponsored trial have yet to verify whether the mechanism of RVX-208 action may affect glucose metabolism. TSX Exchange Symbol: RVX CALGARY, July 23, 2014 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) announced today findings from the recent analysis of Major Adverse Cardiovascular Events (MACE) data in patients with diabetes mellitus (DM) enrolled in both the ASSURE and SUSTAIN trials. In ASSURE, MACE was a pre-specified...

2014-07-17 08:28:35

CARLSBAD, Calif., July 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 2 study evaluating ISIS-APO(a)(Rx) in patients with high lipoprotein(a), or Lp(a), an independent risk factor for cardiovascular disease. Patients with high levels of Lp(a) have an increased risk of atherosclerosis, coronary heart disease, aortic stenosis, heart attack and stroke. ISIS-APO(a)(Rx) is designed to reduce Lp(a) by inhibiting the production of...

2014-07-09 08:29:03

INDIANAPOLIS, July 9, 2014 /PRNewswire/ -- Chek Diagnostics, the U.S.-based manufacturer of both the CardioChek® brand and the A1CNow® family of point-of-care diagnostic products, announced today that it has signed a marketing, sales, and distribution agreement with Independent Medical Co-Op, Inc. (IMCO), one of the premier associations for independent medical distributors. IMCO is a cooperative association of over 140 medical supply distributors that serve the physician, hospital,...

2014-06-27 23:05:56

As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the University of Pittsburgh Graduate School of Public Health discovered. Pittsburgh, Pennsylvania (PRWEB) June 27, 2014 As hormone levels change during the transition to menopause, the quality of a woman’s cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the...

2014-06-25 08:30:43

The lives of millions of Americans are potentially at risk. NEW YORK, June 25, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) urges the FDA to thoughtfully consider new and almost irrefutable proof that high triglycerides are a significant risk factor contributing to cardiovascular disease-related death and morbidity. http://photos.prnewswire.com/prnvar/20140625/121320 This past week, two independent studies were published in the prestigious New England Journal of...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related